These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

51 related items for PubMed ID: 7786399

  • 21. Design and synthesis of novel tyrosine kinase inhibitors using a pharmacophore model of the ATP-binding site of the EGF-R.
    Traxler P, Furet P, Mett H, Buchdunger E, Meyer T, Lydon N.
    J Pharm Belg; 1997; 52(2):88-96. PubMed ID: 9193132
    [Abstract] [Full Text] [Related]

  • 22. A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002).
    Vlahos CJ, Matter WF, Hui KY, Brown RF.
    J Biol Chem; 1994 Feb 18; 269(7):5241-8. PubMed ID: 8106507
    [Abstract] [Full Text] [Related]

  • 23. Relationship between flavonoid structure and inhibition of phosphatidylinositol 3-kinase: a comparison with tyrosine kinase and protein kinase C inhibition.
    Agullo G, Gamet-Payrastre L, Manenti S, Viala C, Rémésy C, Chap H, Payrastre B.
    Biochem Pharmacol; 1997 Jun 01; 53(11):1649-57. PubMed ID: 9264317
    [Abstract] [Full Text] [Related]

  • 24. Inhibitors of phosphatidylinositol signalling as antiproliferative agents.
    Powis G, Phil D.
    Cancer Metastasis Rev; 1994 Mar 01; 13(1):91-103. PubMed ID: 8143348
    [Abstract] [Full Text] [Related]

  • 25. The inhibition of phosphatidylinositol 3-kinase by quercetin and analogs.
    Matter WF, Brown RF, Vlahos CJ.
    Biochem Biophys Res Commun; 1992 Jul 31; 186(2):624-31. PubMed ID: 1323287
    [Abstract] [Full Text] [Related]

  • 26. Inhibition of cell growth in culture by quinones.
    Kamei H, Koide T, Kojima T, Hashimoto Y, Hasegawa M.
    Cancer Biother Radiopharm; 1998 Jun 31; 13(3):185-8. PubMed ID: 10850354
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Laboratory and clinical studies of some quinol diphosphates and related compounds as chemical radiosensitizers and the development of a radioactive drug.
    MARRIAN DH, MARSHALL B, MITCHELL JS.
    Chemotherapia (Basel); 1961 Jun 31; 3():225-310. PubMed ID: 14470193
    [No Abstract] [Full Text] [Related]

  • 30. Direct sequential C-H iodination/organoyl-thiolation for the benzenoid A-ring modification of quinonoid deactivated systems: a new protocol for potent trypanocidal quinones.
    Jardim GAM, Oliveira WXC, de Freitas RP, Menna-Barreto RFS, Silva TL, Goulart MOF, da Silva Júnior EN.
    Org Biomol Chem; 2018 Mar 07; 16(10):1686-1691. PubMed ID: 29450434
    [Abstract] [Full Text] [Related]

  • 31. Complete phenotypic recovery of an Alzheimer's disease model by a quinone-tryptophan hybrid aggregation inhibitor.
    Scherzer-Attali R, Pellarin R, Convertino M, Frydman-Marom A, Egoz-Matia N, Peled S, Levy-Sakin M, Shalev DE, Caflisch A, Gazit E, Segal D.
    PLoS One; 2010 Jun 14; 5(6):e11101. PubMed ID: 20559435
    [Abstract] [Full Text] [Related]

  • 32. Novel quinone antiproliferative inhibitors of phosphatidylinositol-3-kinase.
    Frew T, Powis G, Berggren M, Gallegos A, Abraham RT, Ashendel CL, Zalkow LH, Hudson C, Gruszecka-Kowalik E, Burgess EM.
    Anticancer Drug Des; 1995 Jun 14; 10(4):347-59. PubMed ID: 7786399
    [Abstract] [Full Text] [Related]

  • 33. Advances with phospholipid signalling as a target for anticancer drug development.
    Powis G, Berggren M, Gallegos A, Frew T, Hill S, Kozikowski A, Bonjouklian R, Zalkow L, Abraham R, Ashendel C.
    Acta Biochim Pol; 1995 Jun 14; 42(4):395-403. PubMed ID: 8852330
    [Abstract] [Full Text] [Related]

  • 34. Bacterial lipopolysaccharide induces the association and coordinate activation of p53/56lyn and phosphatidylinositol 3-kinase in human monocytes.
    Herrera-Velit P, Reiner NE.
    J Immunol; 1996 Feb 01; 156(3):1157-65. PubMed ID: 8557993
    [Abstract] [Full Text] [Related]

  • 35. Tyrosine kinase inhibitors. 6. Structure-activity relationships among N- and 3-substituted 2,2'-diselenobis(1H-indoles) for inhibition of protein tyrosine kinases and comparative in vitro and in vivo studies against selected sulfur congeners.
    Showalter HD, Sercel AD, Leja BM, Wolfangel CD, Ambroso LA, Elliott WL, Fry DW, Kraker AJ, Howard CT, Lu GH, Moore CW, Nelson JM, Roberts BJ, Vincent PW, Denny WA, Thompson AM.
    J Med Chem; 1997 Feb 14; 40(4):413-26. PubMed ID: 9046331
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Novel quinone antiproliferative inhibitors of phosphatidylinositol-3-kinase.
    Frew T, Powis G, Berggren M, Gallegos A, Abraham RT, Ashendel CL, Zalkow LH, Hudson C, Gruszecka-Kowalik E, Burgess EM.
    Anticancer Drug Des; 1995 Jun 14; 10(4):347-59. PubMed ID: 7786399
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Tyrosine kinase inhibitors. 6. Structure-activity relationships among N- and 3-substituted 2,2'-diselenobis(1H-indoles) for inhibition of protein tyrosine kinases and comparative in vitro and in vivo studies against selected sulfur congeners.
    Showalter HD, Sercel AD, Leja BM, Wolfangel CD, Ambroso LA, Elliott WL, Fry DW, Kraker AJ, Howard CT, Lu GH, Moore CW, Nelson JM, Roberts BJ, Vincent PW, Denny WA, Thompson AM.
    J Med Chem; 1997 Feb 14; 40(4):413-26. PubMed ID: 9046331
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 3.